[1] Bray F, Ferlay J, Soerjomataram I et al[J]. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, 68, 394-424(2018).

[2] Dummer R, Hauschild A, Pentheroudakis G et al. Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up[J]. Annals of Oncology, 20, iv129-iv131(2009).

[3] Li B H, Chen T L, Lin L et al. Recent progress in photodynamic therapy: from fundamental research to clinical applications[J]. Chinese Journal of Lasers, 49, 0507101(2022).

[4] Kousis P C, Henderson B W, Maier P G et al. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils[J]. Cancer Research, 67, 10501-10510(2007).

[5] Liu Z, Feng L Z. Perspectives on photo-functional nanomaterials and cancer phototherapy[J]. Chinese Journal of Luminescence, 41, 1339-1342(2020).

[6] Kim S, Kim S A, Nam G H et al. In situ immunogenic clearance induced by a combination of photodynamic therapy and Rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis[J]. Journal for Immunotherapy of Cancer, 9, e001481(2021).

[7] Nasr S, Rady M, Sebak A et al. A naturally derived carrier for photodynamic treatment of squamous cell carcinoma: in vitro and in vivo models[J]. Pharmaceutics, 12, 494(2020).

[8] Yang W J, Zhang F W, Deng H Z et al. Smart nanovesicle mediated immunogenic cell death through tumor microenvironment modulation for effective photodynamic immunotherapy[J]. ACS Nano, 14, 620-631(2019).

[9] Cheng H W, Fan X S, Ye E Y et al. Dual tumor microenvironment remodeling by glucose-contained radical copolymer for MRI-guided photoimmunotherapy[J]. Advanced Materials, 34, e2107674(2022).

[10] He S S, Li J C, Cheng P H et al. Charge-reversal polymer nano-modulators for photodynamic immunotherapy of cancer[J]. Angewandte Chemie (International Ed. in English), 60, 19355-19363(2021).

[11] Xiao M, Fan J L, Li M et al. A photosensitizer-inhibitor conjugate for photodynamic therapy with simultaneous inhibition of treatment escape pathways[J]. Biomaterials, 257, 120262(2020).

[12] Liu H F, Wang S J, Xin J et al. Role of NKG2D and its ligands in cancer immunotherapy[J]. American Journal of Cancer Research, 9, 2064-2078(2019).

[13] Korbelik M, Sun J H. Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line[J]. International Journal of Cancer, 93, 269-274(2001).

[14] Theodoraki M N, Lorenz K, Lotfi R et al. Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer[J]. Photodiagnosis and Photodynamic Therapy, 19, 194-201(2017).

[15] Deng G J, Sun Z H, Li S P et al. Cell-membrane immunotherapy based on natural killer cell membrane coated nanoparticles for the effective inhibition of primary and abscopal tumor growth[J]. ACS Nano, 12, 12096-12108(2018).

[16] Parkhurst M R, Riley J P, Dudley M E et al. Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression[J]. Clinical Cancer Research, 17, 6287-6297(2011).

[17] Barth M J, Chu Y Y, Hanley P J et al. Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma[J]. British Journal of Haematology, 173, 597-616(2016).

[18] Luo D, Dong X W, Yan B et al. MG132 selectively upregulates MICB through the DNA damage response pathway in A549 cells[J]. Molecular Medicine Reports, 19, 213-220(2019).

[19] Yang F Q, Liu M, Yang F P et al. Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma[J]. Actas Urológicas Españolas, 38, 172-178(2014).

[20] Tao P, Fisher J F, Mobashery S et al. DFT studies of the ring-opening mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2[J]. Organic Letters, 11, 2559-2562(2009).

[21] Nagase H, Fields G B. Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides[J]. Biopolymers, 40, 399-416(1996).

[22] Kobayashi H, Watanabe R, Choyke P L. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?[J]. Theranostics, 4, 81-89(2013).

[23] Li X P, Zhang T. Research progress of organelles targeting photosensitizers[J]. Acta Laser Biology Sinica, 29, 295-301(2020).

[24] Luo M Y, Li H X, Han D H et al. Inhibition of autophagy enhances apoptosis induced by Ce6-photodynamic therapy in human colon cancer cells[J]. Photodiagnosis and Photodynamic Therapy, 36, 102605(2021).

[25] Ding L, Lin X, Lin Z G et al. Cancer cell-targeted photosensitizer and therapeutic protein co-delivery nanoplatform based on a metal-organic framework for enhanced synergistic photodynamic and protein therapy[J]. ACS Applied Materials & Interfaces, 12, 36906-36916(2020).

[26] Mroz P, Yaroslavsky A, Kharkwal G B et al. Cell death pathways in photodynamic therapy of cancer[J]. Cancers, 3, 2516-2539(2011).

[27] Wang R R, Cui D D, Shi Y J. Photosensitive AgBr@PLGA nanoprobes for near-infrared second region tumor-specific photoacoustic imaging[J]. Chinese Journal of Lasers, 49, 2007204(2022).

[28] Liu C, Lai H Q, Chen T F. Boosting natural killer cell-based cancer immunotherapy with selenocystine/transforming growth factor-beta inhibitor-encapsulated nanoemulsion[J]. ACS Nano, 14, 11067-11082(2020).

[29] Voskoboinik I, Whisstock J C, Trapani J A. Perforin and granzymes: function, dysfunction and human pathology[J]. Nature Reviews Immunology, 15, 388-400(2015).